Statin Use in Outpatients With Obstructive Coronary Artery Disease | Zendy

Suzanne V. Arnold | Zendy; John A. Spertus | Zendy; Fengming Tang | Zendy; Harlan M. Krumholz | Zendy; William B. Borden | Zendy; Steven A. Farmer | Zendy; Henry H. Ting | Zendy; Paul S. Chan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Statin Use in Outpatients With Obstructive Coronary Artery Disease

Author(s) -

Suzanne V. Arnold,

John A. Spertus,

Fengming Tang,

Harlan M. Krumholz,

William B. Borden,

Steven A. Farmer,

Henry H. Ting,

Paul S. Chan

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.038265

Subject(s) - medicine , ezetimibe , statin , coronary artery disease , myocardial infarction , cardiology , revascularization , clinical trial , cholesterol

Clinical trials have shown that statin therapy reduces cardiovascular morbidity and mortality in patients with coronary artery disease (CAD), even among patients with low-density lipoprotein cholesterol levels <100 mg/dL. We sought to determine the extent to which patients with obstructive CAD in routine outpatient care are treated with statins, nonstatins, or no lipid-lowering therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research